Advanced Enzyme — 360° view

Advanced Enzyme, a company in the Biotechnology industry, reported revenue of ₹215 crore and net profit of ₹51 crore for the September 2026 quarter.

Advanced Enzyme (NSE: ADVENZYMES) closed at ₹290.45 on 20 Nov 2026, down 10.7% over the past year. Its market capitalisation is ₹3,182 crore and it trades at 19.6 times earnings.

Share price
₹290.45 (20 Nov 2026)
Market cap
₹3,182 Cr (20 Nov 2026)
P/E
19.57 (20 Nov 2026)
Revenue
₹215 Cr (September 2026 quarter)
Net profit
₹51 Cr (September 2026 quarter)
ROCE
14.0% (FY26)
ROE
10.5% (FY26)
Book value
₹149 (FY26)
Dividend yield
0.46% (last 12 months to 20 Nov 2026)
52-week high / low
₹419.00 / ₹246.80 (20 Nov 2026)
1-year return
-10.7% (to 20 Nov 2026)
Sector
Healthcare
Industry
Biotechnology
Symbol
NSE: ADVENZYMES

Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.